These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes. Vergès B; Florentin E; Baillot-Rudoni S; Monier S; Petit JM; Rageot D; Gambert P; Duvillard L Diabetologia; 2008 Aug; 51(8):1382-90. PubMed ID: 18535816 [TBL] [Abstract][Full Text] [Related]
6. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. Packard CJ; Gaw A; Demant T; Shepherd J J Lipid Res; 1995 Jan; 36(1):172-87. PubMed ID: 7706942 [TBL] [Abstract][Full Text] [Related]
8. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects. Barrett PH; Baker N; Nestel PJ J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038 [TBL] [Abstract][Full Text] [Related]
9. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. Demant T; Bedford D; Packard CJ; Shepherd J J Clin Invest; 1991 Nov; 88(5):1490-501. PubMed ID: 1939641 [TBL] [Abstract][Full Text] [Related]
10. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy. Taskinen MR; Matikainen N; Björnson E; Söderlund S; Inkeri J; Hakkarainen A; Parviainen H; Sihlbom C; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J Diabetologia; 2023 Dec; 66(12):2307-2319. PubMed ID: 37775612 [TBL] [Abstract][Full Text] [Related]
11. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202 [TBL] [Abstract][Full Text] [Related]
12. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Anber V; Millar JS; McConnell M; Shepherd J; Packard CJ Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2507-14. PubMed ID: 9409221 [TBL] [Abstract][Full Text] [Related]
13. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585 [TBL] [Abstract][Full Text] [Related]
14. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998 [TBL] [Abstract][Full Text] [Related]